While few studies have revealed the biological properties of brassicasterol, a phytosterol, against some biological and molecular targets, it is believed that there are still many activities yet to be studied. In this work, brassicasterol exerts a therapeutic utility in an in vitro setting against herpes simplex virus type 1 (HSV-1) and Mycobacterium tuberculosis (Mtb) as well as a considerable inhibitory property against human angiotensin-converting enzyme (ACE) that plays a dynamic role in regulating blood pressure. The antireplicative effect of brassicasterol against HSV-1 is remarkably detected (50% inhibitory concentration (IC50): 1.2 µM; selectivity index (SI): 41.7), while the potency of its effect is ameliorated through the combination with standard acyclovir with proper SI (IC50: 0.7 µM; SI: 71.4). Moreover, the capacity of this compound to induce an adequate level of antituberculosis activity against all Mtb strains examined (minimum inhibitory concentration values ranging from 1.9 to 2.4 µM) is revealed. The anti-ACE effect (12.3 µg/mL; 91.2% inhibition) is also ascertained. Molecular docking analyses propose that the mechanisms by which brassicasterol induces anti-HSV-1 and anti-Mtb might be related to inhibiting vital enzymes involved in HSV-1 replication and Mtb cell wall biosynthesis. In summary, the obtained results suggest that brassicasterol might be promising for future anti-HSV-1, antituberculosis, and anti-ACE drug design.

Department of Applied Ecology Faculty of Environmental Sciences Czech University of Life Sciences Prague Kamýcká 129 6 Suchdol 16521 Prague Czech Republic

See more in PubMed

Hassan S.T., Masarčíková R., Berchová K. Bioactive natural products with anti-herpes simplex virus properties. J. Pharm. Pharmacol. 2015;67:1325–1336. doi: 10.1111/jphp.12436. PubMed DOI

Brezáni V., Leláková V., Hassan S.T.S., Berchová-Bímová K., Nový P., Klouček P., Maršík P., Dall’Acqua S., Hošek J., Šmejkal K. Anti-Infectivity against Herpes Simplex Virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from Eucalyptus globulus Labill. Viruses. 2018;10:360. doi: 10.3390/v10070360. PubMed DOI PMC

Hassan S.T.S., Šudomová M., Berchová-Bímová K., Šmejkal K., Echeverría J. Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties. Molecules. 2019;24:2912. doi: 10.3390/molecules24162912. PubMed DOI PMC

Čulenová M., Sychrová A., Hassan S.T.S., Berchová-Bímová K., Svobodová P., Helclová A., Michnová H., Hošek J., Vasilev H., Suchý P., et al. Multiple In vitro biological effects of phenolic compounds from Morus alba root bark. J. Ethnopharmacol. 2020;248:112296. doi: 10.1016/j.jep.2019.112296. PubMed DOI

Hassan S.T.S., Šudomová M., Masarčíková R. Herpes simplex virus infection: An overview of the problem, pharmacologic therapy and dietary measures. Ceska Slov. Farm. 2017;66:95–102. PubMed

Hassan S.T.S., Berchová-Bímová K., Petráš J., Hassan K.T.S. Cucurbitacin B interacts synergistically with antibiotics against Staphylococcus aureus clinical isolates and exhibits antiviral activity against HSV-1. S. Afr. J. Bot. 2017;108:90–94. doi: 10.1016/j.sajb.2016.10.001. DOI

Widener R.W., Whitley R.J. Herpes simplex virus. Handb. Clin. Neurol. 2014;123:251–263. PubMed

Hassan S.T.S., Švajdlenka E., Berchová-Bímová K. Hibiscus sabdariffa L. and Its Bioactive Constituents Exhibit Antiviral Activity against HSV-2 and Anti-enzymatic Properties against Urease by an ESI-MS Based Assay. Molecules. 2017;22:722. doi: 10.3390/molecules22050722. PubMed DOI PMC

Šudomová M., Shariati M.A., Echeverría J., Berindan-Neagoe I., Nabavi S.M., Hassan S.T.S. A Microbiological, Toxicological, and Biochemical Study of the Effects of Fucoxanthin, a Marine Carotenoid, on Mycobacterium tuberculosis and the Enzymes Implicated in Its Cell Wall: A Link Between Mycobacterial Infection and Autoimmune Diseases. Mar. Drugs. 2019;17:641. doi: 10.3390/md17110641. PubMed DOI PMC

Bell L.C.K., Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection. Nat. Rev. Microbiol. 2018;16:80–90. doi: 10.1038/nrmicro.2017.128. PubMed DOI

Shingadia D. The diagnosis of tuberculosis. Pediatr. Infect. Dis. J. 2012;31:302–305. doi: 10.1097/INF.0b013e318249f26d. PubMed DOI

Hassan S.T.S., Šudomová M., Berchová-Bímová K., Gowrishankar S., Rengasamy K.R.R. Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations. J. Clin. Med. 2018;7:226. doi: 10.3390/jcm7080226. PubMed DOI PMC

Dookie N., Rambaran S., Padayatchi N., Mahomed S., Naidoo K. Evolution of drug resistance in Mycobacterium tuberculosis: A review on the molecular determinants of resistance and implications for personalized care. J. Antimicrob. Chemother. 2018;73:1138–1151. doi: 10.1093/jac/dkx506. PubMed DOI PMC

World Health Organization Fact Sheet on Tuberculosis (2020) [(accessed on 25 March 2020)]; Available online: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.

Hassan S.T.S., Berchová-Bímová K., Šudomová M., Malaník M., Šmejkal K., Rengasamy K.R.R. In Vitro Study of Multi-Therapeutic Properties of Thymus bovei Benth. Essential Oil and Its Main Component for Promoting Their Use in Clinical Practice. J. Clin. Med. 2018;7:283. doi: 10.3390/jcm7090283. PubMed DOI PMC

Li X., Chang P., Wang Q., Hu H., Bai F., Li N., Yu J. Effects of Angiotensin-Converting Enzyme Inhibitors on Arterial Stiffness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cardiovasc. Ther. 2020;2020:7056184. doi: 10.1155/2020/7056184. PubMed DOI PMC

Peng H., Carretero O.A., Vuljaj N., Liao T.D., Motivala A., Peterson E.L., Rhaleb N.E. Angiotensin-converting enzyme inhibitors: A new mechanism of action. Circulation. 2005;112:2436–2445. doi: 10.1161/CIRCULATIONAHA.104.528695. PubMed DOI PMC

Izzo J.L., Jr., Weir M.R. Angiotensin-converting enzyme inhibitors. J. Clin. Hypertens. (Greenwich) 2011;13:667–675. doi: 10.1111/j.1751-7176.2011.00508.x. PubMed DOI PMC

Vanmierlo T., Popp J., Kölsch H., Friedrichs S., Jessen F., Stoffel-Wagner B., Bertsch T., Hartmann T., Maier W., von Bergmann K., et al. The plant sterol brassicasterol as additional CSF biomarker in Alzheimer’s disease. Acta Psychiatr. Scand. 2011;124:184–192. doi: 10.1111/j.1600-0447.2011.01713.x. PubMed DOI

Bianconi V., Mannarino M.R., Sahebkar A., Cosentino T., Pirro M. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk. Curr. Cardiol. Rep. 2018;20:53. doi: 10.1007/s11886-018-0994-7. PubMed DOI

CFR-Code Federal Regulations: Title 21 (2019) [(accessed on 25 March 2020)]; Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=101.83.

Liland N.S., Pittman K., Whatmore P., Torstensen B.E., Sissener N.H. Fucosterol Causes Small Changes in Lipid Storage and Brassicasterol Affects some Markers of Lipid Metabolism in Atlantic Salmon Hepatocytes. Lipids. 2018;53:737–747. doi: 10.1002/lipd.12083. PubMed DOI

Liland N.S., Espe M., Rosenlund G., Waagbø R., Hjelle J.I., Lie Ø., Fontanillas R., Torstensen B.E. High levels of dietary phytosterols affect lipid metabolism and increase liver and plasma TAG in Atlantic salmon (Salmo salar L.) Br. J. Nutr. 2013;110:1958–1967. doi: 10.1017/S0007114513001347. PubMed DOI

Clinical and Laboratory Standards Institute . Laboratory Detection and Identification of Mycobacteria. 1st ed. Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2008. Approved Guideline; CLSI Document M48-A.

Clinical and Laboratory Standards Institute . Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. 2nd ed. CLSI; Wayne, PA, USA: 2011. Approved Standard M24-A2. PubMed

Hassan S.T.S., Švajdlenka E. Biological Evaluation and Molecular Docking of Protocatechuic Acid from Hibiscus sabdariffa L. as a Potent Urease Inhibitor by an ESI-MS Based Method. Molecules. 2017;22:1696. doi: 10.3390/molecules22101696. PubMed DOI PMC

Field H.J., Vere Hodge R.A. Recent developments in anti-herpesvirus drugs. Br. Med. Bull. 2013;106:213–249. doi: 10.1093/bmb/ldt011. PubMed DOI

Treml J., Gazdová M., Šmejkal K., Šudomová M., Kubatka P., Hassan S.T.S. Natural Products-Derived Chemicals: Breaking Barriers to Novel Anti-HSV Drug Development. Viruses. 2020;12:154. doi: 10.3390/v12020154. PubMed DOI PMC

Jung Y.E.G., Schluger N.W. Advances in the diagnosis and treatment of latent tuberculosis infection. Curr. Opin. Infect. Dis. 2020;33:166–172. doi: 10.1097/QCO.0000000000000629. PubMed DOI

Wächter G.A., Franzblau S.G., Montenegro G., Hoffmann J.J., Maiese W.M., Timmermann B.N. Inhibition of Mycobacterium tuberculosis growth by saringosterol from Lessonia nigrescens. J. Nat. Prod. 2001;64:1463–1464. doi: 10.1021/np010101q. PubMed DOI

Tan M.A., Takayama H., Aimi N., Kitajima M., Franzblau S.G., Nonato M.G. Antitubercular triterpenes and phytosterols from Pandanus tectorius Soland. var. laevis. J. Nat. Med. 2008;62:232–235. doi: 10.1007/s11418-007-0218-8. PubMed DOI

Olugbuyiro J.A., Moody J.O., Hamann M.T. Phytosterols from Spondias mombin Linn with Antimycobacterial Activities. Afr. J. Biomed. Res. 2013;16:19–24. PubMed PMC

Chinsembu K.C. Tuberculosis and nature’s pharmacy of putative anti-tuberculosis agents. Acta Trop. 2016;153:46–56. doi: 10.1016/j.actatropica.2015.10.004. PubMed DOI

Šudomová M., Hassan S.T.S., Khan H., Rasekhian M., Nabavi S.M. A Multi-Biochemical and In Silico Study on Anti-Enzymatic Actions of Pyroglutamic Acid against PDE-5, ACE, and Urease Using Various Analytical Techniques: Unexplored Pharmacological Properties and Cytotoxicity Evaluation. Biomolecules. 2019;9:392. doi: 10.3390/biom9090392. PubMed DOI PMC

Hagiwara H., Wakita K., Inada Y., Hirose S. Fucosterol decreases angiotensin converting enzyme levels with reduction of glucocorticoid receptors in endothelial cells. Biochem. Biophys. Res. Commun. 1986;139:348–352. doi: 10.1016/S0006-291X(86)80120-6. PubMed DOI

Xie Y., Wu L., Wang M., Cheng A., Yang Q., Wu Y., Jia R., Zhu D., Zhao X., Chen S., et al. Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets. Front. Microbiol. 2019;10:941. doi: 10.3389/fmicb.2019.00941. PubMed DOI PMC

Schang L.M., St Vincent M.R., Lacasse J.J. Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs. Antivir. Chem. Chemother. 2006;17:293–320. doi: 10.1177/095632020601700601. PubMed DOI

Viegas D.J., Edwards T.G., Bloom D.C., Abreu P.A. Virtual screening identified compounds that bind to cyclin dependent kinase 2 and prevent herpes simplex virus type 1 replication and reactivation in neurons. Antiviral. Res. 2019;172:104621. doi: 10.1016/j.antiviral.2019.104621. PubMed DOI

Schang L.M. The cell cycle, cyclin-dependent kinases, and viral infections: New horizons and unexpected connections. Prog. Cell. Cycle Res. 2003;5:103–124. PubMed

Schang L.M., Phillips J., Schaffer P.A. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J. Virol. 1998;72:5626–5637. doi: 10.1128/JVI.72.7.5626-5637.1998. PubMed DOI PMC

Davido D.J., Leib D.A., Schaffer P.A. The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0. J. Virol. 2002;76:1077–1088. doi: 10.1128/JVI.76.3.1077-1088.2002. PubMed DOI PMC

Schang L.M., Bantly A., Schaffer P.A. Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. J. Virol. 2002;76:7724–7735. doi: 10.1128/JVI.76.15.7724-7735.2002. PubMed DOI PMC

Wang H., Kim N.H. CDK2 Is Required for the DNA Damage Response During Porcine Early Embryonic Development. Biol. Reprod. 2016;95:31. doi: 10.1095/biolreprod.116.140244. PubMed DOI

Tadesse S., Caldon E.C., Tilley W., Wang S. Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update. J. Med. Chem. 2019;62:4233–4251. doi: 10.1021/acs.jmedchem.8b01469. PubMed DOI

Soltero-Higgin M., Carlson E.E., Gruber T.D., Kiessling L.L. A unique catalytic mechanism for UDP-galactopyranose mutase. Nat. Struct. Mol. Biol. 2004;11:539–543. doi: 10.1038/nsmb772. PubMed DOI

Abrahams K.A., Besra G.S. Mycobacterial cell wall biosynthesis: A multifaceted antibiotic target. Parasitology. 2018;145:116–133. doi: 10.1017/S0031182016002377. PubMed DOI PMC

Natesh R., Schwager S.L., Evans H.R., Sturrock E.D., Acharya K.R. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry. 2004;43:8718–8724. doi: 10.1021/bi049480n. PubMed DOI

Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers

Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways